To this aim, we investigated the mechanism of radioresistance conferred by c-Met in melanoma based on previous work indicating that some RTKs could activate PARP1 enzymatic activity by distinct mechanisms which are cancer dependent (25, 26). This evidence concerns the gene MET and cancer.